Traders often assume that a seasonal pattern guarantees direction. That is an error. Treat every pattern as a probability ...

The first beats are born as stick figures discover the power of sound. Canada's Florida boycott 'taking effect' on Donald Trump—Doug Ford This hockey mom exposed a youth-sports theft. Then came the ...

The Quarter-final fixtures of the ongoing FIFA U-17 World Cup in Qatar have been confirmed. This follows the conclusion of the Round of 16 fixtures played on Tuesday. DAILY POST reports that Morocco ...

Tathvamasi Studios has dropped the first full gameplay trailer for SURI: The Seventh Note, a rhythm action platformer coming to PS5 and PC as part of Sony’s India Hero Project. Set on the island of ...

The naira continued its appreciation against the United States dollar on Friday at the official foreign exchange market, ending the week on a good note. Data from the Central Bank of Nigeria showed ...

It's been a sad week for Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), who've watched their investment drop 12% to US$98.49 in the week since the company reported its third-quarter result. The statutory ...

Completed in July the sale of TimeBase, the Company’s Australia subsidiary, to Thomson Reuters for total consideration of $6.5 million. Launched in July an additional expansion of PolicyNote with ...

Related reads:Suri: The Seventh Note – PlayStation India Hero Project-Backed Studio, Tathvamasi, Reveals First Look at Its 2D Metroidvania PS5 Game Tathvamasi Studios has revealed the gameplay trailer ...

We measure our business using both financial and operating metrics to assess the near-term and long-term performance of our overall business, including identifying trends, formulating financial ...

Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results And Business Update. -- Third quarter 2025 net product revenue from global sales of IMCIVREE^® (setmelanotide) of $51.3 ...

BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...